Yttrium (90Y) tacatuzumab tetraxetan: Difference between revisions
Content deleted Content added
Anypodetos (talk | contribs) Partly sourced |
m Remove unref category as article appears to have one or more refs or a tag. using AWB |
||
| Line 26: | Line 26: | ||
}} |
}} |
||
'''Tacatuzumab tetraxetan''' is a [[ |
'''Tacatuzumab tetraxetan''' is a [[humanize]]d [[monoclonal antibody]] used to treat cancer.{{Citation needed|date=October 2009}} Tacatuzumab it attached to a [[chelator]], [[tetraxetan]], which binds a [[radioisotope]], [[yttrium-90]].<ref>[http://apps.who.int/medicinedocs/documents/s14179e/s14179e.pdf WHO Drug Information]</ref> |
||
==References== |
==References== |
||
| Line 33: | Line 33: | ||
{{humanizedmonoclonals}} |
{{humanizedmonoclonals}} |
||
{{DEFAULTSORT:Tacatuzumab Tetraxetan}} |
|||
[[Category:Monoclonal antibodies]] |
[[Category:Monoclonal antibodies]] |
||
[[Category:Articles lacking sources (Erik9bot)]] |
|||
[[Category:Cancer treatments]] |
[[Category:Cancer treatments]] |
||
{{monoclonal-antibody-stub}} |
{{monoclonal-antibody-stub}} |
||
Revision as of 20:10, 8 October 2009
| Monoclonal antibody | |
|---|---|
| Type | ? |
| Source | Human |
| Target | α-fetoprotein |
| Clinical data | |
| ATC code |
|
| Identifiers | |
| CAS Number | |
| Chemical and physical data | |
| Formula | C6470H9971N1712O2007S4290Y |
| Molar mass | 145 kDa |
Tacatuzumab tetraxetan is a humanized monoclonal antibody used to treat cancer.[citation needed] Tacatuzumab it attached to a chelator, tetraxetan, which binds a radioisotope, yttrium-90.[1]
References
 | This monoclonal antibody–related article is a stub. You can help Wikipedia by expanding it. |